Write in a clean editor, then format for Neuro-Oncology in one click — DocuGuru applies the official Oxford University Press template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Neuro-Oncology is a peer-reviewed journal published by Oxford University Press, covering Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging. Over its lifetime it has published 29,958 papers, which have received 309,063 citations.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Numbered (OUP) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, and C. Lee, A representative article title, Neuro-Oncology 12 (2023) 45–58.
Formats any DOI in the closest standard style — Neuro-Oncology has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Glioma Diagnosis and Treatment Brain Metastases and Treatment Radiomics and Machine Learning in Medical Imaging Cancer, Hypoxia, and Metabolism Meningioma and schwannoma management |
| ISSN | 1522-8517 |
| Citation impact (2-yr) | 1.02 |
| h-index | 217 |
| i10-index | 3,109 |
| Article processing charge | $4,612 |
| Top institutions publishing here | University of California, San Francisco |
| Journal website | neuro-oncology.oxfordjournals.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the CDC and NCI, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary…
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to…
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains…
Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI), is the largest population-based cancer registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US…
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis,…
